EUF’s “Principle of Organospecificity” serves fundamentally for replacement and consequently for the restoration and the regeneration of the matched molecules. EUF’s low molecular mass of the organic ingredients served as a prerequisite for the absorption through the instant mucosa and the skin. The supply of ‘biological building blocks’ on the molecular level is what makes the therapy efficient.
In addition, the essential electromagnetic elements contained within the fetal organs and tissues are also vital in delivering cellular information to the control mechanism of individual cells and their inter-relationships with various other cells, tissues and organs. EUF visible response will take about 3 to 4 weeks upon application to the body from the first date of use. The chain reaction of ‘absorption – transport – incorporation’ has to take its course in order for the efficient functional/structural improvement to be observed.
FCTI EUF do not replace stem cell therapy for the treatment of incurable or no longer treatable diseases, but they complement stem cell therapy.
